191 related articles for article (PubMed ID: 6976987)
1. The purification and properties of human T cell growth factor.
Mier JW; Gallo RC
J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987
[TBL] [Abstract][Full Text] [Related]
2. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.
Mier JW; Gallo RC
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6134-8. PubMed ID: 6969402
[TBL] [Abstract][Full Text] [Related]
3. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
Frank MB; Watson J; Mochizuki D; Gillis S
J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
Gillis S; Smith KA; Watson J
J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
[TBL] [Abstract][Full Text] [Related]
6. Purification of human B cell growth factor.
Mehta SR; Conrad D; Sandler R; Morgan J; Montagna R; Maizel AL
J Immunol; 1985 Nov; 135(5):3298-302. PubMed ID: 3876383
[TBL] [Abstract][Full Text] [Related]
7. Properties of a surface antigen expressed on activated human thymus-derived lymphocytes.
Udey MC; Jendrisak MD; Parker CW
J Immunol; 1982 Apr; 128(4):1870-5. PubMed ID: 6801123
[TBL] [Abstract][Full Text] [Related]
8. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
Schwyzer M; Fontana A
J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
[TBL] [Abstract][Full Text] [Related]
9. Purification and partial characterization of human intracellular B cell growth factor.
Sahasrabuddhe CG; Martin B; Maizel AL
Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330
[TBL] [Abstract][Full Text] [Related]
10. Purification and biochemical characterization of human lymphocyte mitogenic factor (LMF).
Rutenberg WD; al-Khalidi U; Rosen FS; Merler E
J Immunol; 1979 Feb; 122(2):723-7. PubMed ID: 310850
[TBL] [Abstract][Full Text] [Related]
11. Purification of avian T cell growth factor and immune interferon using gel filtration high resolution chromatography.
Fredericksen TL; Sharma JM
Prog Clin Biol Res; 1987; 238():145-56. PubMed ID: 3110790
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous profiles of a factor that renders neutrophils cytotoxic obtained from a concanavalin A-stimulated spleen cell culture in partial purification process.
Fujii Y; Inoue T; Ito M; Kimura S; Fuyama S; Arai S; Naiki M; Sendo F
J Immunol; 1986 May; 136(10):3693-9. PubMed ID: 3701059
[TBL] [Abstract][Full Text] [Related]
13. Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells.
Brown WC; Grab DJ
J Immunol; 1985 Nov; 135(5):3184-90. PubMed ID: 3930599
[TBL] [Abstract][Full Text] [Related]
14. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
Welte K; Wang CY; Mertelsmann R; Venuta S; Feldman SP; Moore MA
J Exp Med; 1982 Aug; 156(2):454-64. PubMed ID: 6980256
[TBL] [Abstract][Full Text] [Related]
15. Identification and purification of human T-lymphocyte colony-enhancing factor, TLCEF: increased production by phorbol myristate acetate.
Werber MM; Goldman J; Radnay J; Klein S; Rozenszajn LA
Immunology; 1985 Oct; 56(2):285-93. PubMed ID: 3876981
[TBL] [Abstract][Full Text] [Related]
16. Partial purification and characterization of the human lymphocyte colony enhancing factor (LCEF).
Zeevi A; Goldman I; Rozenszajn LA
Immunology; 1978 Mar; 34(3):523-31. PubMed ID: 305893
[TBL] [Abstract][Full Text] [Related]
17. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.
Schrader JW; Clark-Lewis I
J Immunol; 1982 Jul; 129(1):30-5. PubMed ID: 6979567
[TBL] [Abstract][Full Text] [Related]
18. A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification.
Dell'Aquila ML; Pigott DA; Bonaquist DL; Gaffney EV
J Natl Cancer Inst; 1984 Feb; 72(2):291-8. PubMed ID: 6582317
[TBL] [Abstract][Full Text] [Related]
19. A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line.
Gootenberg JE; Ruscetti FW; Gallo RC
J Immunol; 1982 Oct; 129(4):1499-505. PubMed ID: 6980938
[TBL] [Abstract][Full Text] [Related]
20. In vitro growth of cytotoxic human lymphocytes. III. The preparation of lectin-free T cell growth factor (TCGF) and an analysis of its activity.
Lotze MT; Rosenberg SA
J Immunol; 1981 Jun; 126(6):2215-20. PubMed ID: 6453159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
